Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow oxygen ...
Inogen, in partnership with Yuwell, has taken another step toward becoming a comprehensive respiratory solutions company with ...
Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen ...
Inogen (INGN +5.2%) rose pre-market following its Q4 results on Feb. 24 post market. Q4 total revenue rose 3.3% Y/Y to $76.4M, missing analysts' estimates of $76.60M. The increase was mainly driven by ...
Inogen (INGN) shares soared 5.1% in the last trading session to close at $27.82. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
Inogen (NASDAQ:INGN) shareholders have endured a 85% loss from investing in the stock five years ago
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held Inogen, Inc. (NASDAQ:INGN) for half a ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2025 financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback